Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: Follow-up of population based Perth MONICA cohort, 1984-2005

BMJ (Online)

Volumn 338, Issue 7690, 2009, Pages 341-344

  Briffa, Tom ^a   Hickling, S ^a   Knuiman, M ^a   Hobbs, M ^a   Hung, J ^b   Sanfilippo, F M ^a   Jamrozik, K ^c   Thompson, P L ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY RISK; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SURVIVAL ANALYSIS; WESTERN AUSTRALIA;

EID: 61849184188     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b36     Document Type: Article

References (34)

1. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet 2000;355:688-700.
2. Beaglehole R, Stewart AW, Jackson R, Dobson AJ, McElduff P, D'Este K, et al. Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. Am J Epidemiol 1997;145:707-13.
3. McElduff P, Dobson A, Jamrozik K, Hobbs M. The WHO MONICA study in Australia, 1984-93: a summary of the Newcastle and Perth MONICA projects. Canberra: Australian Institute of Health and Welfare; 2000. (Report No AIHW, Cat No 11.)
4. Thompson PL, Nidorf SM, Parsons RW, Jamrozik KD, Hobbs MS. The benefits of beta-blockade at the time of myocardial infarction. J Hypertens Suppl 1991;9:S35-7.
5. Czarn AO, Jamrozik K, Hobbs MS, Thompson PL. Follow-up care after acute myocardial infarction. Med J Aust 1992;157:302-5.
6. ISIS-2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (second international study of infarct survival) collaborative group. Lancet 1988;2:349-60.
7. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260:2088-93.
8. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration. BMJ 1988;296:320-31.
9. Lagerqvist B, Husted S, Kontny F, Naslund U, Stahle E, Swahn E, et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol 2002;40:1902-14.
10. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized intervention trial of unstable angina. Lancet 2002;360:743-51.
11. Department of Health. National service framework (NSF) for coronary heart disease. London: DH, 2000.
12. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
13. Martin CA, Chung KC, Lim W, Wong KK. The problem of home management in the estimation of the incidence of acute myocardial infarction from hospital records. J Chronic Dis 1986;39:683-6.
14. Martin CA, Hobbs MS, Armstrong BK. Estimation of myocardial infarction mortality from routinely collected data in Western Australia. J Chronic Dis 1987;40:661-9.
15. Martin CA, Hobbs MS, Armstrong BK, de Klerk NH. Trends in the incidence of myocardial infarction in Western Australia between 1971 and 1982. Am J Epidemiol 1989;129:655-68.
16. Jamrozik K, Dobson AJ, Hobbs MS, McElduff P, Ring I, D'Este K, et al. Monitoring the incidence of cardiovascular disease in Australia. Canberra: Australian Institute of Health and Welfare, 2001. (Cardiovascular Disease Series No 17; AIHW Cat No CVD 16.)
17. Norman PE, Semmens JB, Lawrence-Brown MMD, Holman CDJ. Long term relative survival after surgery for population based study abdominal aortic aneurysm in Western Australia. BMJ 1998;317:852-6.
18. Jacobs DR Jr, Kroenke C, Crow R, Deshpande M, Gu DF, Gatewood L, et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation 1999;100:599-607.
19. Hobbs MST, McCaul KA, Knuiman MW, Rankin JM, Gilfillan I. Trends in coronary artery revascularisation procedures in Western Australia, 1980-2001. Heart 2004;90:1036-41.
20. Herlitz J, Bang A, Sjolin M, Karlson BW. Five-year mortality after acute myocardial infarction in relation to previous history, level of care, complications in hospital, and medication at discharge. Cardiovasc Drugs Ther 1996;10:485-90.
21. Botkin NF, Spencer FA, Goldberg RJ, Lessard D, Yarzebski J, Gore JM. Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J 2006;151:199-205.
22. Hobbs MS, Knuiman MW, Briffa TG, Ngo H, Jamrozik K. Plasma cholesterol levels continue to decline despite the rising prevalence of obesity: population trends in Perth, Western Australia, 1980-1999. Eur J Cardiovasc Prev Rehabil 2008;15:319-24.
23. Capewell S, Livingston BM, MacIntyre K, Chalmers JWT, Boyd J, Finlayson A, et al. Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J 2000;21:1833-40.
24. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol 2008;51:1247-54.
25. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996;124:999-1005.
26. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
27. McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Blackburn H, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation 2001;104:19-24.
28. McGovern PG, Folsom AR, Sprafka JM, Burke GL, Doliszny KM, Demirovic J, et al. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. The Minnesota Heart Survey. Circulation 1992;85:172-9.
29. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-90.
30. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999;33:1533-9.
31. Sala J, Marrugat J, Masia R, Porta M, The Regicor I. Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR Study. Eur Heart J 1995;16:779-84.
32. Taylor R, Dobson A, Mirzaei M. Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades. Eur J Cardiovasc Prev Rehabil 2006;13:760-8.
33. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
34. Kattainen A, Salomaa V, Harkanen T, Jula A, Kaaja R, Kesaniemi YA, et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J 2006;27:296-301.